Plc Glaxosmithkline serves as Executive at EPIX Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Plc Glaxosmithkline has executed 135 insider transactions totaling $4.2B, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 2, 2021 involved exercising options for 635,646 shares valued at $0.
Plc Glaxosmithkline currently holds 732,583 shares of EPIX Pharmaceuticals, Inc. (EPIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Plc Glaxosmithkline has been a net seller of EPIX stock. They have purchased $1.6B and sold $2.6B worth of shares.
Plc Glaxosmithkline's most recent insider trade was on Jul 2, 2021, when they sold 635,646 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 2, 2021 | CVRX | $5.0M | Purchase | 275,000 | $18.00 | Discretionary |
| Jul 2, 2021 | CVRX | $0 | Conversion | 8,380 | $N/A | Discretionary |
| Jul 2, 2021 | CVRX | $0 | Conversion | 1,505 | $N/A | Discretionary |
| Jul 2, 2021 | CVRX | $0 | Conversion | 12,979 | $N/A | Discretionary |
| Jul 2, 2021 | CVRX | $0 | Conversion | 14,917 | $N/A | Discretionary |
| Jun 21, 2021 | LYEL | $0 | Conversion | 30,253,189 | $N/A | Discretionary |
| May 20, 2021 | INVA | $392.1M | Sale | 32,005,260 | $12.25 | Discretionary |
| Feb 17, 2021 | DBTX | $2.7M | Purchase | 150,000 | $18.00 | Discretionary |
| Feb 17, 2021 | DBTX | $0 | Conversion | 458,487 | $N/A | Discretionary |
| Feb 17, 2021 | DBTX | $0 | Conversion | 247,324 | $N/A | Discretionary |
| Feb 17, 2021 | DBTX | $0 | Conversion | 327,852 | $N/A | Discretionary |
| Jul 24, 2020 | GNCA | $2.8M | Purchase | 1,260,504 | $2.25 | Discretionary |
| Jul 21, 2020 | PAND | $0 | Conversion | 348,469 | $N/A | Discretionary |
| Jul 21, 2020 | PAND | $6.5M | Purchase | 361,111 | $18.00 | Discretionary |
| Jul 21, 2020 | PAND | $0 | Conversion | 1,538,724 | $N/A | Discretionary |
| Jul 15, 2020 | BCYC | $59.5K | Sale | 3,069 | $19.40 | Discretionary |
| Jul 15, 2020 | BCYC | $1.5K | Sale | 78 | $19.25 | Discretionary |
| Jul 14, 2020 | NKTX | $0 | Conversion | 525,499 | $N/A | Discretionary |
| Jul 14, 2020 | NKTX | $0 | Conversion | 1,712,810 | $N/A | Discretionary |
| Jul 14, 2020 | NKTX | $15.0M | Purchase | 833,333 | $18.00 | Discretionary |
| Jul 14, 2020 | NKTX | $0 | Conversion | 79,090 | $N/A | Discretionary |
| Jul 14, 2020 | BCYC | $30.8K | Sale | 1,597 | $19.27 | Discretionary |
| May 21, 2020 | TPTX | $5.0M | Purchase | 83,333 | $60.00 | Discretionary |
| May 20, 2020 | PGNY | $103.0M | Sale | 4,000,000 | $25.75 | Discretionary |
| Oct 29, 2019 | PGNY | $0 | Conversion | 9,821,190 | $N/A | Discretionary |
| Oct 18, 2019 | PRNB | $10.0M | Purchase | 357,142 | $28.00 | Discretionary |
| Sep 10, 2019 | TPTX | $8.0M | Purchase | 177,777 | $45.00 | Discretionary |
| Jul 22, 2019 | FULC | $0 | Conversion | 1,785,714 | $N/A | Discretionary |